C
VAR

Cerebellum’s Varian Medical Systems, Inc. VAR Stock Holding History

Cerebellum’s Portfolio VAR Stock Details VAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$63K Buy
+368
New +$57.9K 0.29% 229

Other funds holding VAR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Cerebellum's VAR Position: Q3 2020 in Review

Cerebellum opened a new position in Varian Medical Systems, Inc. (VAR) in Q3 2020: 368 shares worth $63K. The stake represents 0.29% of the portfolio and ranks #229 among its holdings.

642 funds tracked by Wall St. Rank hold VAR as of Q3 2020.

  • Cerebellum held 368 shares of Varian Medical Systems, Inc. worth $63K as of Q3 2020.
  • Varian Medical Systems, Inc. was a new Cerebellum position in Q3 2020.
  • Varian Medical Systems, Inc. made up 0.29% of Cerebellum's portfolio in Q3 2020, its #229 holding.
  • 642 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.